Markets
U.S. open in 6 hrs, 38 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
CardioGenics Holdings Inc. Announces Name, Ticker Symbol and CUSIP Number Change
PR Newswire
MISSISSAUGA, Ontario, Oct. 26 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board: JAGH) has received notification from FINRA that the name and ticker symbol change for the Company on the OTCBB will take place at the beginning of business on Tuesday, October 27, 2009. The new ticker symbol for "CardioGenics Holdings Inc." on the OTC Bulletin Board will be "CGNH". In addition to the name and ticker symbol change that is scheduled to take place tomorrow on the OTC Bulletin Board, the CUSIP for the Company's common stock will also change tomorrow to 14160X 104. For reference of the official change, please visit the following link:
http://www.otcbb.com/asp/dailylist_detail.asp?mkt_ctg=OTCBB&d=10/26/2009
.
About CardioGenics Holdings Inc.
Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the
In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.
SOURCE CardioGenics Holdings Inc.
2009-10-26 17:25:00
COMMENTS ( 0 )